The team of Fierce Pharma has analyzed data of the 11 largest pharmaceutical companies and evaluated which company generates the most sales with new (in the last 5 years brought to market) drugs and this also related to the total sales (drugs).
I find this extremely interesting, as drug sales completely collapse once the patent expires and cheap generics enter the market.
In this regard, it is good to know that companies with current drugs are well positioned for the coming years.
Here is the full article:
